10 NOV 2025 · CONFERENCE
Advancing circular mRNA therapeutics in Asia
At RNA Therapeutics & Manufacturing Asia, Byterna discussed circular mRNA innovation and in vivo CAR-T development.
Andy Xian Zeng moderated a C-suite discussion on advancing RNA medicines toward clinical reality and presented Byterna’s work in circular mRNA therapeutics and in vivo CAR-T.
The conference update describes the company’s platform direction and does not report clinical results.